Gamlaphen
| Gamlaphen | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 220.31 g/mol [1] |
| Predicted LogP | 1.3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H20N2O |
| IUPAC name | 4-amino-N-(1-phenylpropan-2-yl)butanamide |
| SMILES | CC(CC1=CC=CC=C1)NC(=O)CCCN |
| InChI | InChI=1S/C13H20N2O/c1-11(15-13(16)8-5-9-14)10-12-6-3-2-4-7-12/h2-4,6-7,11H,5,8-10,14H2,1H3,(H,15,16) |
| InChIKey | ZCEDFZCLWZXZGC-UHFFFAOYSA-N |
| PubChem CID | 26657 |
Gamlaphen (also known as 4-amino-N-(1-phenylpropan-2-yl)butanamide) is a substance of the amphetamine class.
Chemistry
Stereochemistry []
Gamlaphen is a racemic mixture of the enantiomers.
Druglikeness
Lipinski's rule of five
Gamlaphen matches Lipinski's rule of five.See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 26657, Gamlaphen. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/26657
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 10:00:33 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 10:00:29 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 10:00:29 |
| gsrs | missing (no UNII) | 2026-11-20 10:00:29 |
| hmdb | missing (no HMDB id) | 2026-11-20 10:00:29 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 10:00:30 |
| pubchem | ok | 2026-11-20 10:00:29 |
| missing (no r/tripreports posts mention it) | 2026-11-20 10:00:29 | |
| sider | missing (not in SIDER) | 2026-11-20 10:00:29 |
| structure | ok | 2026-11-20 10:00:29 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 10:00:29 |